Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cervical Cancer Survival Rates

Has relative survival improved?

Over the past three decades, relative survival has improved for women with stage I-III cervical cancer but has changed little for those individuals with metastatic disease, according to a study of 46,932 patients whose changes in stage-specific relative survival with cervical cancer were compared to the general population matched by age, race, and calendar year. Results from the study indicated:

• For women with stage I tumors, the excess hazard ratio in 2009 was 0.91 compared to 0.81 in 2000, and 0.75 in 1983.

• For women with stage III tumors, the excess hazard ratios for patients diagnosed in 2009 were 0.83, 0.68, and 0.59, respectively, for the same time period.

• Similar trends in improved survival rates over time were observed for stage II patients.

Citation: Wright JD, Chen L, Tergas AI, et al. Population-Level Trends in Relative Survival for Cervical Cancer. American Journal of Obstetrics & Gynecology. [Published online ahead of print July 22, 2015]. doi: 10.1016/j.ajog.2015.07.012.